Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin

Figure 4

Analysis of tumor histology after oxaliplatin treatment. A) No significant difference in tumor necrosis was observed between the control group and oxaliplatin treatment group after treatment. B) Terminal transferase dUTP nick end labeling (TUNEL) analysis showed a basal level of apoptosis rate of about 3% in tumors of the control group throughout the 2-week experiment. In the oxaliplatin treatment group, significant apoptosis was observed on day 2 after the final injection (B, C). No significant difference in apoptosis was found between the two groups at other time points.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us